QQ客服 官方微博 反馈留言

	AKR1C3, as a novel target of DAB2IP signaling, maintains the protein stability of androgen receptor splicing variant in prostate cancer
	Wu, Kaijie; Wang, Bin; Hsieh, Jer-Tsong; He, Dalin
刊名	INTERNATIONAL JOURNAL OF UROLOGY
	2018
卷号	25页码:211-211
ISSN号	0919-8172
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2830102
专题	西安交通大学
推荐引用方式 GB/T 7714	Wu, Kaijie,Wang, Bin,Hsieh, Jer-Tsong,et al. AKR1C3, as a novel target of DAB2IP signaling, maintains the protein stability of androgen receptor splicing variant in prostate cancer[J]. INTERNATIONAL JOURNAL OF UROLOGY,2018,25:211-211.
APA	Wu, Kaijie,Wang, Bin,Hsieh, Jer-Tsong,&He, Dalin.(2018).AKR1C3, as a novel target of DAB2IP signaling, maintains the protein stability of androgen receptor splicing variant in prostate cancer.INTERNATIONAL JOURNAL OF UROLOGY,25,211-211.
MLA	Wu, Kaijie,et al."AKR1C3, as a novel target of DAB2IP signaling, maintains the protein stability of androgen receptor splicing variant in prostate cancer".INTERNATIONAL JOURNAL OF UROLOGY 25(2018):211-211.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。